WHAT IS KNOWN ALREADY: Miscarriages have been associated with increased long-term cardiovascular disease risk, and arterial and cardiovascular dysfunction has been hypothesised as the common link. It is not known if these risks are present prior to pregnancy or are a reflection of poor arterial and haemodynamic adaptation to pregnancy. STUDY DESIGN, SIZE, DURATION: This prospective longitudinal preconception cohort study was conducted over 18 months. In total, 367 participants were recruited pre-pregnancy, from which 197 pregnancies were recorded; 39 of these pregnancies ended in first trimester miscarriage. Complete longitudinal data were available for 172 pregnancies (140 viable pregnancies, 32 first trimester miscarriages) from prepregnancy to 6 weeks gestation.
Introduction
In a healthy pregnancy, major physiological changes of haemodynamic and arterial function occur early in the first trimester, including a substantial increase in cardiac output (CO) and a reduction in both peripheral vascular resistance (PVR) and augmentation index (a measure of arterial wave reflection) (Capeless and Clapp, 1989; Robson et al., 1989; Mahendru et al., 2012) . The sub-clinical phase of pre-eclampsia and intrauterine growth restriction (IUGR) is associated with abnormalities in haemodynamic and arterial function (Duvekot et al., 1995; Mahendru et al., 2012) . These cardiovascular parameters are of clinical importance as they are also associated with long-term cardiovascular disease (CVD) risk (Laurent et al., 2006) . Haemodynamic and arterial dysfunction has been postulated as the link that explains a higher risk of CVD later in life for women who experience these disorders during pregnancy (Ness and Sibai, 2006; Bellamy et al., 2007; Newstead et al., 2007) .
Recent evidence suggests, that women with spontaneous pregnancy loss, that is, miscarriages rather than termination of pregnancy, also have a higher risk of future CVD. A meta-analysis of over half a million women reported that those with a history of miscarriage had greater odds of developing heart disease (OR 1.45), with a strong association between recurrent miscarriage and coronary heart disease (OR = 1.99) (Oliver-Williams et al., 2013) . After controlling for common risk factors between miscarriage and CVD, including obesity and smoking, an association between the disorders is still evident, with a dosedependent relationship found with two or more miscarriages (Smith et al., 2003; Kharazmi et al., 2012) . Interestingly, the arterial dysfunction that occurs in pre-eclampsia and IUGR is also postulated to underlie the pathogenic mechanisms of recurrent miscarriage (Germain et al., 2007) .
It could be hypothesised that a sub-set of women have a predisposition to haemodynamic or arterial dysfunction, and in response to the increasing physiological stress of pregnancy, experience complications such as miscarriage as an early manifestation, or growth restriction/pre-eclampsia as a later manifestation of this dysfunction (Staff et al., 2016) . These same women might therefore be predisposed to a higher risk of CVD later in life due to compounded age-related changes. It is not known whether such a predisposition exists and is unmasked by pregnancy or alternatively whether there are haemodynamic differences prior to the pregnancy.
No previous studies have reported arterial or haemodynamic changes in pregnancies that end in first-trimester miscarriage. Our objective, using a prospective longitudinal cohort methodology, was to explore pre-pregnancy haemodynamic and arterial function in cases of first trimester miscarriage compared to that in healthy ongoing pregnancy.
Materials and Methods

Recruitment
Patients were recruited within the CONCEIVE study, an ongoing observational study that follows women from preconception to post-delivery with an objective to investigate cardiovascular changes in relation to pregnancy complications. (The full study protocol is summarised in Fig. 1 .) Here we describe pre-pregnancy and early first trimester changes in relation to miscarriage. We do not plan to revisit this analysis; we do however intend to analyse the data in relation to late pregnancy complications such as preeclampsia or IUGR.
Women were recruited via promotional posters, media advertisements and social medial platforms. Potential participants were screened for study inclusion criteria before a first study visit was organised, during which time participants would consent to study entry. Inclusion criteria included women aged 18-44 actively trying for a pregnancy. Exclusion criteria for were body mass index >35, smokers, pregnancy, history of recurrent miscarriages (three consecutive or more), unexplained sub-fertility, and pre-existing comorbidities such as essential hypertension, diabetes, thrombophilia, renal disease or polycystic ovarian syndrome (PCOS).
Study protocol
A pre-pregnancy study visit was conducted at least 1 month after stopping contraception, and in the early follicular phase of the cycle. At this visit, participants underwent baseline cardiovascular assessments and exercise testing as described in detail below. Participants were also given a personalised digital home urinary ovulation and pregnancy testing kit (SPD Development Ltd, Bedford, UK), which would help optimise their chances of conceiving, and allow the research team to track timing of ovulation and implantation, such that planned follow-up visits could be as gestational age specific as possible. Participants did daily ovulation testing from cycle Day 6 until they obtained a 'peak' reading on the digital monitor, which, based on previous literature, indicated ovulation within the next 20 h (Baird et al., 1991) . They commenced pregnancy testing from 6 days following a 'peak' reading till three consecutive positive pregnancy test readings or commencement of the next menstrual cycle.
Once pregnant, participants were followed up longitudinally with repeat cardiovascular assessments at 6, 10, 22 and 34 weeks gestation and 6 weeks post-partum.
Cardiovascular measurements
Participants were requested to refrain from caffeinated drinks for at least 4 h prior to their assessments. Cardiovascular measurements were initiated after 10 min of rest in the sitting position. Brachial blood pressure (BP) and heart rate (HR) were measured in the dominant arm using an automated BP measuring device (Omron-M7, White Medical, UK) that has been validated for use in pregnancy (de Greeff et al., 2009) . All measurements were performed in duplicate, with the participant sitting with their legs uncrossed.
The aortic augmentation index (AIx), a measure of arterial wave reflections, was obtained with a cuff-based device (Vicorder, Smart Medical, UK) that has been validated against assessment methods such as tonometry (Davies et al., 2012; Pucci et al., 2013; Shahin et al., 2013) . With the participant lying in a left lateral tilt at rest for 10 min, a brachial pressure reading was obtained, calibrated and digitally computed by the Vicorder with an arm cuff, statically inflated to 70 mmHg using a volume displacement technique. The first and second central systolic peaks were identified by the software and used to calculate AIx.
While the participant remained in the left lateral position, a measurement of pulse wave velocity (PWV), a measure of arterial stiffness, was obtained by placing a 10 cm wide BP cuff around the upper right thigh for measurement of the femoral pulse and by placing a 3 cm partial cuff around the neck at the level of the carotid artery. The path-length was calculated according manufacturer's instructions, from the suprasternal notch to a defined point on the upper part of the femoral cuff. The cuffs were inflated to 65 mmHg and two high quality waveforms were simultaneously recorded for 3 s using volume displacement, from which the carotidfemoral PWV was automatically derived. CO was assessed using a non-invasive, inert gas re-breathing technique (Innocor, Innovision A/S, Denmark) which has been validated against invasive assessments of cardiac function (Gabrielsen et al., 2002) . CO is the volume of blood pumped by the heart per unit of time (litres/minute). In the left lateral position, the participant continuously re-breathes a gas mixture: 1% sulphur hexafluoride (SF 6 ), 5% nitrous oxide (N 2 O) and 94% oxygen (O 2 ) over 20 s, with a breathing rate of 20/min. Expired gases are sampled continuously and analysed by an infrared photoacoustic gas analyser for the determination of CO. The rate of dissipation of N 2 O is proportional to the pulmonary blood flow, and hence the higher the CO, the higher the dissipation rate of this gas. The tests were repeated with the participant standing.
Cardiac index (CI) was derived from formula: CO (L/min)/body surface area (m 2 )
PVR was derived from the formula: PVR (dynes/s/cm
First trimester foetal viability assessment
Pregnancy viability was assessed at 6 weeks gestation using transvaginal ultrasound. Any women diagnosed as having any pregnancy complication was referred to the participant's local early pregnancy unit, and managed according to local clinical guidelines.
Data analysis
Pre-pregnancy measurements
All participants had cardiovascular measurements prior to pregnancy. Based on subsequent outcome when they became pregnant, they were allocated into two groups for data analysis. Group 1 consisted of women who conceived and had a viable pregnancy beyond the first trimester; Group 2 were women who conceived but were diagnosed as having a first trimester miscarriage. We excluded five cases of pregnancy (two termination of pregnancy for chromosomal abnormality, one ectopic pregnancy and two second trimester miscarriages).
Participants who experienced a very early miscarriage (taken as less than 6 weeks gestation) were retained in the study without the need to repeat pre-pregnancy tests. If they then conceived another pregnancy which continued to at least 6 weeks gestation, their pre-pregnancy and 6-week data were allocated to either the control group (Group 1) or miscarriage group (Group 2) based on subsequent outcome. Participants who conceived, and experienced a miscarriage after 6 weeks but before 12 weeks (defined as clinically recognised pregnancy loss) were allocated to the first trimester miscarriage group (Group 2). If they subsequently returned into the study, pre-pregnancy cardiovascular tests were repeated and these values were used in relation to any future index pregnancy (viable or miscarriage) for data analysis.
Pregnancy measurements
When participants were pregnant, cardiovascular measurements were repeated at 6 weeks gestation of pregnancy. Only asymptomatic participants were assessed at this visit. Seven participants who had symptoms (abdominal pain, vaginal bleeding) prior to their 6-week study visit were advised to attend their local hospital for clinical assessment. All seven women subsequently experienced an early miscarriage, with a negative pregnancy test confirmed after resolution of symptoms, but prior to their initially planned 6-week study visit. No pregnancy cardiovascular assessments were therefore carried out for these women.
For the other asymptomatic pregnant participants, cardiovascular assessments were carried out prior to ultrasound scan, to ensure that measurements were not biased by outcome. Due to subjects lost to follow-up within both control and pathology groups, only 140 out of 153 women and 32 out of 39 women attended their 6-week visit within Groups 1 (controls) and 2 (miscarriages), respectively (see Fig. 2 for recruitment flow-chart). Cross-sectional analyses at 6 weeks gestation, as well as longitudinal analysis of changes in cardiovascular parameters (delta, δ = difference in measurements between 6 weeks gestation and prepregnancy) were examined between the groups.
Statistical analyses
Statistical analyses were performed using the Statistical Package for Social Sciences (Version 18.0.0, 2009, SPSS, Chicago, IL, USA). The normality of distribution was examined with Shapiro-Wilks test. For parametric data, a t-test was used to compare means; a Mann-Whitney U-test was used for non-parametric variables. Data are displayed as means ± SD. A P value of <0.05 was taken to indicate significance.
Ethical approval
The study was approved by the East of Scotland one Research Ethics Committee (REC Reference No: 14/ES/1046).
Results
A total of 367 women were recruited preconception, of whom 35 withdrew or were lost to subsequent study follow-up. Of the remaining 332 women, 197 pregnancies were recorded; a conception rate of 59.3%. Of these pregnancies, 153 were viable beyond the first trimester, and 39 pregnancies resulted in a first trimester miscarriage, which consisted of 32 miscarriages diagnosed beyond 6 weeks gestation, and seven miscarriages prior to 6 weeks gestation. A further five pregnancies were excluded due to termination of pregnancy (n = 2), ectopic pregnancy (n = 1) and spontaneous second trimester loss (n = 2).
Maternal characteristics are summarised in Table I .
Pre-pregnancy cardiovascular measurements
There were no differences in pre-pregnancy peripheral BP (systolic or diastolic) or mean arterial pressure (MAP) between Group 1 who were the controls with subsequent viable pregnancies beyond the first trimester and Group 2 who were women who subsequently had a first trimester miscarriage.
No differences between the groups were found in pre-pregnancy measurements of CO, CI or PVR, nor in arterial function as denoted by AIx and PWV. These results are summarised in Table II .
Six weeks gestation cardiovascular measurements
A few participants missed their 6-week pregnancy visit, and therefore data at 6 weeks was only available in 140 out of 153 women in Group 1 and in 32 out of 39 women in Group 2. The interval between the prepregnancy and 6-week cardiovascular assessments was 4.1 and 3.9 decimal months in Group 1 and Group 2, respectively. When comparing similar cross-sectional cardiovascular measurements at 6 weeks gestation, women who subsequently experienced a miscarriage had similar central haemodynamic measurements and arterial function to those having successful pregnancy. These results are summarised in Table III .
Pre-pregnancy to 6-week cardiovascular changes
We measured the longitudinal change (delta) in cardiovascular parameters from pre-pregnancy to 6 weeks gestation in relation to pregnancy viability, which reflects individual cardiovascular adaptation in response to pregnancy.
PVR decreased from pre-pregnancy to 6 weeks of pregnancy in both Group 1 (controls) and Group 2 (miscarriage) in both lying (controls: −209.1 ± 255.6, miscarriage −158.7 ± 230.9) and standing (controls: −219.7 ± 396.7, miscarriage −178.7 ± 471.6) positions, but there was no significant difference in magnitude of the delta change between the groups. Overall, there was an increase in CO from pre-pregnancy to 6 weeks gestation (lying: controls 1.0 ± 1.3, miscarriage 0.7 ± 1.4; standing: controls 0.5 ± 1.0, miscarriage 0.4 ± 1.2); the degree of increment was comparable between Group 1 and Group 2. The adaptation of arterial function to early pregnancy was also similar between the groups. The results are summarised in Table IV .
Discussion
Here we report longitudinal changes in haemodynamic and arterial function in the same women before pregnancy and in early pregnancy. We find that preconception cardiovascular function defined by arterial function, cardiac output or vascular resistance prior to pregnancy is no different in women who have go on to have a viable pregnancy compared to those who miscarry in the first trimester beyond 6 weeks gestation. These findings suggest that there is no obvious haemodynamic or arterial predisposition that increases the risk of having a subsequent miscarriage. Furthermore, we observed a similar adaptation to early pregnancy, in other words a drive towards increased cardiac output and decreasing vascular resistance in pregnancies that miscarry and those that continue to be healthy. This implies that haemodynamic adaptation to early pregnancy is not influenced by the viability or presence of an embryo but that this 'drive' in haemodynamic changes and arterial function may be dependent on circulating factors produced by trophoblastic cells. A 
Table IV
Pre-pregnancy to 6-week cardiovascular changes (delta).
Pre-pregnancy to 6-week gestation changes (delta)
Controls ( possible candidate might be human chorionic gonadotropin (hCG), which has been reported in association with a larger decrease in PVR and a higher increase in cardiac output when administered exogenously to patients undergoing in vitro fertilisation (Manau et al., 2002) . It is therefore plausible to that hCG, produced by trophoblast cells, is responsible for the cardiovascular changes seen. In our cohort, hCG was not measured during pregnancy. All participants who subsequently experienced a miscarriage were asymptomatic at the time of their 6-week assessment, and therefore may still have had high circulating levels of hCG, comparable to those that had viable pregnancies. From published literature (Fritz and Guo, 1987; Kadar and Romero, 1987; Barnhart et al., 2004) , the b-HCG levels at fixed gestations are not clearly discernible between viable and asymptomatic non-viable pregnancies, and are largely dependent on starting b-HCG levels. It is expected that there would be a decline in HCG levels for non-viable pregnancies; this rate of decline is observed to be slower and following a log linear pattern in spontaneously resolving miscarriages (in comparison to those that had medical or surgical management of miscarriage), which is more reflective of our cohort at time of assessments. The increased risk of cardiovascular morbidity that has been noted in women with miscarriages might arise from miscarriage being an independent risk factor for CVD. This is consistent with the finding of a 'dose-dependent effect' of recurrent miscarriages leading to increased cardiovascular risk, compared to women who have just one miscarriage. It could also arise from other associated cardiovascular risk factors which were not explored in this study, for instance dyslipidaemia or insulin insensitivity. In PCOS and insulin dependent diabetes (IDDM), which are associated with endocrine dysfunction and the 'metabolic syndrome', the miscarriage rate is higher and common risk factors, such as increased body mass index and impaired glucose tolerance, are also associated with CVD (Rai et al., 2000; Craig et al., 2002; Zolghadri et al., 2008; Fauser et al., 2012) . In this study, we examined the mechanistic link between haemodynamic and arterial function and miscarriage. While we did not find an association, this does not imply that cardiovascular dysfunction is not associated with miscarriage in conditions such as PCOS and IDDM, although it makes this hypothesis less likely.
A strength of the current study is that the prospective methodology affords a unique opportunity to observe cardiovascular adaptation to pregnancy in an unselected cohort of healthy women without randomising them on the basis of specific characteristics or knowing what their pregnancy outcome will be. While this is the first study to investigate haemodynamic variables and arterial function preconception, and, adaptation to pregnancy in relation to viability, the relatively modest number of miscarriage cases may not be sufficient to show a difference in haemodynamic changes if the difference was subtle.
In conclusion, women who have clinically recognised miscarriages have a similar haemodynamic and arterial function pattern to those who have viable pregnancies beyond the first trimester. This makes a hypothesis suggesting that haemodynamic predisposition or cardiovascular maladaptation to pregnancy with miscarriage is unlikely, but does not exclude a link between miscarriage and future CVD.
